2-氨基-5-溴-3-二甲氨基吡嗪 | 89641-34-9

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 2-氨基-5-溴-3-二甲氨基吡嗪
• 英文名称: 6-bromo-N2,N2-dimethylpyrazine-2,3-diamine
• 英文别名: 2-Amino-5-brom-3-dimethylamino-pyrazin；5-bromo-N³,N³-dimethyl-pyrazine-2,3-diamine；2-amino-5-bromo-3-dimethylaminopyrazine；2-Amino-5-bromo-3-(dimethylamino)pyrazine；5-bromo-3-N,3-N-dimethylpyrazine-2,3-diamine
• CAS: 89641-34-9
• 化学式: C₆H₉BrN₄
• 分子量: 217.068
• InChiKey: FBHYHUKOQSACFX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  55
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 储存条件：
  2-8°C

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Amino-5-bromo-3-(dimethylamino)pyrazine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Amino-5-bromo-3-(dimethylamino)pyrazine
CAS number: 89641-34-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H9BrN4
Molecular weight: 217.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1,3-二氯丙酮 、 2-氨基-5-溴-3-二甲氨基吡嗪 在 alcohol 、 二氯甲烷 作用下， 反应 3.0h， 以6-bromo-2-chloromethyl-8-dimethylaminoimidazo[1,2-a]pyrazine is obtained的产率得到6-bromo-2-chloromethyl-8-dimethylaminoimidazo[1,2-a]pyrazine
  参考文献：
  名称：

  8-alkylaminoimidazo(1,2-a)pyrazines and derivatives, their preparation

  摘要：

  式(I)的新型8-烷基氨基咪唑并[1,2-a]吡嗪具有优良的药理活性。它们可用于人类和兽医治疗的医疗产品，适用于抗痉挛剂、子宫松弛剂、支气管扩张剂、心脏兴奋剂和神经镇静剂等领域。

  公开号：

  US05028605A1
• 作为产物：
  描述：

  2-氨基-3,5-二溴吡嗪 以 乙醇 、 二甲胺 为溶剂， 生成 2-氨基-5-溴-3-二甲氨基吡嗪
  参考文献：
  名称：

  N-heterocyclyl sulphonamide derivatives and their use as endothelin

  摘要：

  这项发明涉及药用价值的N-杂环磺胺衍生物，它们的药用盐，其制备方法，它们在人类或其他温血动物中拮抗内皮素一种或多种作用的用途，以及它们在治疗疾病或医疗状况的方法中的应用，其中内皮素的升高或异常水平起重要致病作用。

  公开号：

  US05861401A1

文献信息

• [EN] N-HETEROCYCLYL SULPHONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS<br/>[FR] DERIVES N-HETEROCYCLYLES SULFONAMIDES ET LEUR UTILISATION EN TANT QU'ANTAGONISTES DE L'ENDOTHELINE
  申请人：ZENECA LIMITED

  公开号：WO1995026957A1

  公开（公告）日：1995-10-12

  (EN) The invention concerns pharmaceutically useful compounds of formula (I), wherein Q is a naphthyl or biphenyl group; W, X, Y and Z are independently selected from nitrogen and CR2 such that two or three of W, X, Y and Z are nitrogen and the remainder are CR2 or X is nitrogen and W, Y and Z are CR2; A1, A2, A3 and R1 have any of the meanings defined herein, and their pharmaceutically acceptable salts, and pharmaceutical compositions containing them. The novel compounds possess endothelin receptor antagonist activity and are useful in the treatment of diseases or medical conditions in which elevated or abnormal levels of endothelin play a significant causative role. The invention further concerns processes for the manufacture of the novel compounds and the use of the compounds in medical treatment.(FR) L'invention concerne des composés de la formule (I), utiles sur le plan pharmaceutique, les sels de ceux-ci pharmacologiquement acceptables ainsi que les compositions pharmaceutiques les contenant. Dans cette formule, Q représente naphtyle ou un groupe biphényle; W, X, Y et Z sont indépendamment choisis parmi azote et CR2 de telle manière que deux ou trois parmi W, X, Y et Z représentent azote, tandis que les autres représentent CR2, ou bien X représente azote et W, Y et Z représentent CR2; A1, A2, A3 et R1 ont une quelconque des notations données dans la description. Ces nouveaux composés possèdent une activité antagoniste dirigée contre le récepteur de l'endothéline et sont utiles dans le traitement des maladies ou affections dans lesquelles des niveaux élevés ou anormaux d'endothéline ont un rôle causal important. En outre, l'invention concerne des procédés de fabrication de ces nouveaux composés et l'utilisation de ceux-ci dans des traitements médicaux.

  该发明涉及公式(I)的在药学上有用的化合物，其中Q是萘基或联苯基；W、X、Y和Z独立地选择自氮和CR2，使得W、X、Y和Z中的两个或三个是氮，其余的是CR2，或者X是氮，W、Y和Z是CR2；A1、A2、A3和R1具有在此定义的任何含义，以及它们的药学上可接受的盐和含有它们的制药组合物。新的化合物具有内皮素受体拮抗剂活性，并且在治疗内皮素水平升高或异常起重要作用的疾病或医学状况中有用。该发明还涉及制造新化合物的过程以及在医疗治疗中使用这些化合物的方法。
• Aryl-substituted pyrimidine sulphonamide compounds as endothelin
  申请人：Zeneca Limited

  公开号：US06083951A1

  公开（公告）日：2000-07-04

  Pyrimidine sulphonamide compounds of the following formula, ##STR1## wherein Q is a naphthyl or biphenyl group either unsubstituted or substituted with A.sup.1, and where A.sup.1, R.sup.1 and R.sup.2 are a variety of alkyl, aryl and cyclic moieties, as described in the specification hereof, which compounds are useful for the treatment of diseases or medical conditions such as hypertension, pulmonary hypertension, cardiac or cerebral circulatory disease and renal disease.

  以下是化学式为##STR1##的嘧啶磺酰胺类化合物，其中Q是萘基或联苯基，可以是未取代或取代的，而A.sup.1、R.sup.1和R.sup.2则是各种烷基、芳基和环状基团，如本说明书所述。这些化合物可用于治疗高血压、肺动脉高压、心脏或脑循环疾病和肾脏疾病等疾病或医疗条件。
• 8-ALKYLAMINOIMIDAZO 1,2-A]PYRAZINES AND DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY
  申请人：BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH

  公开号：EP0348392A1

  公开（公告）日：1990-01-03
• N-HETEROCYCLYL SULPHONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS
  申请人：ZENECA LIMITED

  公开号：EP0752986B1

  公开（公告）日：1999-05-19
• US5028605A
  申请人：——

  公开号：US5028605A

  公开（公告）日：1991-07-02